Cargando…
Tributyrin Inhibits Ethanol-Induced Epigenetic Repression of CPT-1A and Attenuates Hepatic Steatosis and Injury
Ethanol-mediated down-regulation of carnitine palmitoyltransferase-1 (CPT-1A) gene expression plays a major role in the development of hepatic steatosis; however, the underlying mechanisms are not completely elucidated. Tributyrin, a butyrate prodrug that can inhibit histone deacetylase (HDAC) activ...
Autores principales: | Donde, Hridgandh, Ghare, Smita, Joshi-Barve, Swati, Zhang, JingWen, Vadhanam, Manicka V., Gobejishvili, Leila, Lorkiewicz, Pawel, Srivastava, Sanjay, McClain, Craig J., Barve, Shirish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078548/ https://www.ncbi.nlm.nih.gov/pubmed/31654770 http://dx.doi.org/10.1016/j.jcmgh.2019.10.005 |
Ejemplares similares
-
Tributyrin Mitigates Ethanol-Induced Lysine Acetylation of Histone-H3 and p65-NFκB Downregulating CCL2 Expression and Consequent Liver Inflammation and Injury
por: Ghare, Smita S., et al.
Publicado: (2023) -
Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice
por: Singhal, Richa, et al.
Publicado: (2021) -
Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice
por: Chen, Wei-Yang, et al.
Publicado: (2016) -
cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease
por: Elnagdy, Mohamed, et al.
Publicado: (2020) -
Focus on the Liver: Alcohol Use, Highly Active Antiretroviral Therapy, and Liver Disease In HIV-Infected Patients
por: Barve, Shirish, et al.
Publicado: (2010)